Core Viewpoint - China Chemical Engineering Corporation's stock performance and financial metrics indicate a mixed outlook, with a slight decrease in revenue but an increase in net profit, alongside notable changes in shareholder structure and financing activities [1][2][3]. Financing Summary - On September 17, China Chemical's financing buy-in amounted to 49.40 million yuan, while financing repayment reached 71.62 million yuan, resulting in a net financing outflow of 22.21 million yuan [1]. - The total financing and securities balance stood at 2.23 billion yuan, accounting for 4.90% of the circulating market value, which is above the 60th percentile of the past year [1]. - The company had a low short-selling balance of 98.14 million yuan, with a short-selling volume of 13.05 million shares, indicating a lower level of short interest compared to the past year [1]. Financial Performance - For the first half of 2025, China Chemical reported operating revenue of 90.72 billion yuan, a slight decrease of 0.35% year-on-year, while net profit attributable to shareholders increased by 9.26% to 3.10 billion yuan [2]. - Cumulatively, the company has distributed 9.96 billion yuan in dividends since its A-share listing, with 3.30 billion yuan distributed over the past three years [3]. Shareholder Structure - As of June 30, 2025, the number of shareholders decreased by 11.48% to 93,300, while the average number of circulating shares per person increased by 12.45% to 64,756 shares [2]. - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 295 million shares, an increase of 60.66 million shares from the previous period [3].
中国化学9月17日获融资买入4940.42万元,融资余额22.27亿元